You can prescribe AspyreRx™ today

Our online pharmacy partner, PhilRx, makes it easy

How to prescribe

  1. Search ‘AspyreRx’ in your EMR* and prescribe a quantity of one (90-day treatment period) with one refill.

  2. Then search ‘PhilRx’ in your EMR’s retail pharmacy finder to e-prescribe.

  3. Please include the patient’s cellphone number with the prescription and notify them to expect a text from ‘PhilRx’.

*If AsypreRx is not in your EMR, ask your EMR system administrator to ensure the Compendia is fully up to date and contains AspyreRx

eRx: If you can’t locate AspyreRx in your EMR, call in or fax the Rx to PhilRx - details below

Phone: Call in the Rx via phone 855.977.0975, Option 1

Fax: Send Rx via fax number to 888.975.0603

If you are having trouble locating ‘PhilRx’ in the EMR:

  • Search by phone number: 855.977.0975

  • Search by NPI: 1487163598

  • Search by address: 150 E Campus View Blvd, Suite 210, Columbus OH 43235

Insurance coverage

If AspyreRx is not covered under your patient’s health insurance plan, there are options to get patients on treatment.

Start your patients on AspyreRx with minimal effort

Have questions?
We’re here to help.

Indications for use:

AspyreRx is a prescription-only digital therapeutic device intended to provide cognitive behavioral therapy to patients 18 years or older with type 2 diabetes. The device targets behavior to aid in the management of type 2 diabetes in patients who are under the care of a healthcare provider. AspyreRx provides cognitive behavioral therapy as a treatment that should be used adjunctively with standard of care.

Notes regarding indications for use:

  • The device is not intended for use as a stand-alone therapy.

  • The device is not a substitute for a patient’s prescribed therapy or medication.

  • The benefit of treatment with the device was not evaluated beyond 180 days of treatment. The ability of the device to prevent potential relapse into prior behaviors after treatment discontinuation has not been studied.

  • The benefit of the device without the use of study-related compensation for glycemic monitoring has not been evaluated.

  • The device should not be used by people with unstable psychiatric disorders.

  • The device should not be used by people with severe psychiatric disorders and is not intended for use as a treatment for any psychiatric disorder or symptom.